Strong R&D investment, advanced manufacturing technologies, and supportive government policies accelerate global API production growth.Austin, Texas, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Small Molecule ...

The "U.S. Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report by Stage Type (Preclinical, Clinical, Commercial), Customer Type, Therapeutic Area, Region, and Segment ...

Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...

This month, the Joe Biden administration awarded $14 million to the API Innovation Center, a Saint Louis–based nonprofit that aims to remedy supply chain problems for active pharmaceutical ingredients ...

The MarketWatch News Department was not involved in the creation of this content. The global industry was valued at US$ 38.9 Bn in 2022 and is expected to register a CAGR of 7.1% from 2023 to 2031.

Wilmington PharmaTech (“WPT”), a U.S.-based specialty contract research, development, and manufacturing organization (CRDMO) focused on custom small molecule API development and manufacturing, today ...

Raubling, Germany-based Axplora, which focuses on small-molecule API manufacturing reports that its total investments initiated across its global network in 2025 will exceed €100 million ($115.6 ...

TEDA TIANJIN, China--(BUSINESS WIRE)-- Asymchem Laboratories (Tianjin) Co., Ltd. (Stock Code 002821.SZ/6821.HK) announced today that it will operate the former Pfizer U.K. small molecule API pilot ...